Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04223349 · ClinicalTrials.gov registry record · Phase 1

A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants

A Phase 1 study of Healthy, sponsored by Janssen Research & Development.

Completed
Registry status
Phase 1
Development phase
66
Enrollment target
1
Study location

NCT04223349 is a Phase 1 study of Healthy that has completed, run by Janssen Research & Development. The registered enrollment target is 66 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04223349, a Phase 1 study of Healthy, has completed, sponsored by Janssen Research & Development.

COMPLETED
Registry status
Phase 1
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to characterize the pharmacokinetic (PK) of multiple twice-daily doses of JNJ-70033093 in healthy participants and to assess the effects of dosing time and food on the PK of single-dose of JNJ-70033093 in healthy participants.

Conditions Studied

Healthy

Interventions

  • DRUG Placebo
  • DRUG JNJ-70033093

Study Locations (1)

Utah

  • PRA Health Sciences - Salt Lake City

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2020-01-10
Est. Completion 2020-04-08
Phase Phase 1

Sponsor

Janssen Research & Development

593 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04223349

The ClinicalTrials.gov registry entry for NCT04223349 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (90% lower). The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04223349 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT04223349 about?

NCT04223349 is a clinical study titled "A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants". The purpose of this study is to characterize the pharmacokinetic (PK) of multiple twice-daily doses of JNJ-70033093 in healthy participants and to assess the effects of dosing time and food on the PK of single-dose of JNJ-70033093 in healthy participants.

What is the current status of trial NCT04223349?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 66 participants. The study started on 2020-01-10. Estimated completion is 2020-04-08.

What conditions does trial NCT04223349 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT04223349?

The interventions under investigation include: Placebo (DRUG), JNJ-70033093 (DRUG).

Who is sponsoring clinical trial NCT04223349?

This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04223349 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Utah

All trials with a study site in Utah

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.